Want to see HK:2407 full AI Analyst Report?
Total Valuation
Gaush Meditech Ltd. has a market cap or net worth of HK$635.92M. The enterprise value is HK$776.20M.
Market CapHK$635.92M
Enterprise ValueHK$776.20M
Share Statistics
Gaush Meditech Ltd. has 147,887,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding147,887,860
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Gaush Meditech Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.16%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.16%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee1.55M
Profits Per Employee128.43K
Employee Count893
Asset Turnover0.53
Inventory Turnover2.16
Valuation Ratios
The current PE Ratio of Gaush Meditech Ltd. is 7.0. Gaush Meditech Ltd.’s PEG ratio is 2.35.
PE Ratio7.0
PS Ratio0.78
PB Ratio0.64
Price to FCF9.72
Price to Operating Cash Flow3.49
PEG Ratio2.35
Income Statement
In the last 12 months, Gaush Meditech Ltd. had revenue of 1.38B and earned 96.19M in profits. Earnings per share was 0.66.
Revenue1.38B
Gross Profit633.20M
Operating Income121.65M
Pretax Income114.68M
Net Income96.19M
EBITDA203.47M
Earnings Per Share (EPS)0.66
Cash Flow
In the last 12 months, operating cash flow was 150.10M and capital expenditures -23.95M, giving a free cash flow of 126.15M billion.
Operating Cash Flow150.10M
Free Cash Flow126.15M
Free Cash Flow per Share0.85
Dividends & Yields
Gaush Meditech Ltd. pays an annual dividend of HK$0.3, resulting in a dividend yield of 6.98%
Dividend Per ShareHK$0.3
Dividend Yield6.98%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.61
52-Week Price Change-54.06%
50-Day Moving Average4.64
200-Day Moving Average5.62
Relative Strength Index (RSI)38.42
Average Volume (3m)15.64K
Important Dates
Gaush Meditech Ltd. upcoming earnings date is Apr 1, 2027, Before Open (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateApr 1, 2027
Ex-Dividend Date―
Financial Position
Gaush Meditech Ltd. as a current ratio of 2.40, with Debt / Equity ratio of 24.40%
Current Ratio2.40
Quick Ratio1.63
Debt to Market Cap0.42
Net Debt to EBITDA0.33
Interest Coverage Ratio6.21
Taxes
In the past 12 months, Gaush Meditech Ltd. has paid 23.49M in taxes.
Income Tax23.49M
Effective Tax Rate0.20
Enterprise Valuation
Gaush Meditech Ltd. EV to EBITDA ratio is 5.61, with an EV/FCF ratio of 10.32.
EV to Sales0.83
EV to EBITDA5.61
EV to Free Cash Flow10.32
EV to Operating Cash Flow7.91
Balance Sheet
Gaush Meditech Ltd. has HK$358.11M in cash and marketable securities with HK$402.50M in debt, giving a net cash position of -HK$44.38M billion.
Cash & Marketable SecuritiesHK$358.11M
Total DebtHK$402.50M
Net Cash-HK$44.38M
Net Cash Per Share-HK$0.30
Tangible Book Value Per ShareHK$2.91
Margins
Gross margin is 45.82%, with operating margin of 8.81%, and net profit margin of 6.97%.
Gross Margin45.82%
Operating Margin8.81%
Pretax Margin8.31%
Net Profit Margin6.97%
EBITDA Margin14.74%
EBIT Margin8.16%
Analyst Forecast
The average price target for Gaush Meditech Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-5.14%
EPS Growth Forecast-22.72%